Healthcare Triangle Inc (HCTI)
1.47
+0.08
(+5.47%)
USD |
NASDAQ |
Apr 19, 16:00
1.47
0.00 (0.00%)
After-Hours: 20:00
Healthcare Triangle Research and Development Expense (Quarterly): 0.104M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.104M |
| September 30, 2023 | 0.054M |
| June 30, 2023 | 0.102M |
| March 31, 2023 | 0.539M |
| December 31, 2022 | 2.771M |
| September 30, 2022 | 1.471M |
| June 30, 2022 | 0.646M |
| March 31, 2022 | 1.066M |
| Date | Value |
|---|---|
| December 31, 2021 | 1.482M |
| September 30, 2021 | 2.204M |
| June 30, 2021 | 0.813M |
| March 31, 2021 | 0.757M |
| December 31, 2020 | 0.2737M |
| September 30, 2020 | 0.5502M |
| June 30, 2020 | 0.4924M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.054M
Minimum
Sep 2023
2.771M
Maximum
Dec 2022
0.8883M
Average
0.646M
Median
Jun 2022
Research and Development Expense (Quarterly) Benchmarks
| Spok Holdings Inc | 2.642M |
| Ontrak Inc | 1.893M |
| National Research Corp | -- |
| LogicMark Inc | 0.1758M |
| FOXO Technologies Inc | 0.283M |